The registry of the German Network for Systemic Scleroderma: frequency of disease subsets and patterns of organ involvementNicolas Hunzelmann, Valerie Bartels, E. Genth et al.|Lara D. Veeken|2008Cited by 287
European Dermatology Forum S1‐guideline on the diagnosis and treatment of sclerosing diseases of the skin, Part 1: localized scleroderma, systemic sclerosis and overlap syndromesRobert Knobler, Thomas Krieg, G. Bali et al.|Journal of the European Academy of Dermatology and Venereology|2017Cited by 261
A new molecular classification to drive precision treatment strategies in primary Sjögren’s syndromePerrine Soret, Doreen Belz, Christelle Le Dantec et al.|Nature Communications|2021Cited by 166
Recommendations for the use of rituximab (anti‐CD20 antibody) in the treatment of autoimmune bullous skin diseases<sup>§</sup>Michael Hertl, Sonja Wolff‐Franke, Detlef Zillikens et al.|JDDG Journal der Deutschen Dermatologischen Gesellschaft|2008Cited by 137
Local immune effector cell-associated toxicity syndrome in CAR T-cell treated patients with autoimmune disease: an observational studyMelanie Hagen, Georg Schett, Fabian Müller et al.|The Lancet Rheumatology|2025Cited by 71